Figure 1: Assessment of basal 10-year risk of fracture with the 2010 tool of the Canadian Association of Radiologists and Osteoporosis Canada. Figure 1:

Slides:



Advertisements
Similar presentations
Chapter 68 Chapter 68 Fracture Risk Assessment: The Development and Application of FRAX ® Copyright © 2013 Elsevier Inc. All rights reserved.
Advertisements

OSTEOPOROSIS Definitions Definitions Causes Causes Investigations Investigations Treatments Treatments Case studies Case studies.
2010 Guidelines Papaioannou A, et al. CMAJ 2010 Oct 12. [Epub ahead of print] Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis.
Update on Osteoporosis Dr Terence O’Neill Consultant Rheumatologist.
2010 Guidelines Case Study #2: Mrs. BR 2010 Guidelines.
WHO Osteoporosis Definition (1996)
Protelos Long-Term Antifracture Efficacy. Protelos Vertebral Antifracture Efficacy over 4 years in SOTI Favors Protelos  RR P
OSC Recommendations for Bone Mineral Density Reporting Slides prepared by Kerry Siminoski, MD, FRCPC William Leslie, M.Sc., MD,
1 Ipriflavone in the Treatment of Postmenopausal Osteoporosis Randomized placebo-controlled, 4-year study conducted Europe 475 postmenopausal white women,
May 28 – 30, 2015, Montréal, Québec AN UNDERAPPRECIATED CAUSE OF MORBIDITY Sian E. Iles MD Associate Professor Dalhousie University Halifax Nova Scotia.
“Known knowns, known unknowns, unknown unknowns….. Ronald Dumsfeld Senior Lecturer in Metabolic Bone Diseases.
Chapter 83 Chapter 83 Denosumab for the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
A Look at Osteoporosis Screening Guidelines Cynthia Phelan PGY
Estrogen plus Progestin, BMD and Fractures: Women’s Health Initiative Jane A. Cauley University of Pittsburgh JAMA 2003; 290 (13) :
1 A Scoping Review of Strategies for the Prevention of Hip Fracture in Elderly Nursing Home Residents Anna Sawka, Nofisat Ismailia, Ann Cranney, Lehana.
RCP bone health and NHFD database Neil Pendleton Senior lecturer Geriatric Medicine University of Manchester and Salford Royal NHS Foundation Trust.
Jacobi Ambulatory Care Service The next steps…. Jacobi Ambulatory Care Service Doing More by doing less Tips.
Review: Osteoporosis Dr Roland Halil, BSc(Hon), BScPharm, ACPR, PharmD
Prevention and Treatment of Osteoporosis
R1 김형오 / Prof. 김덕윤 1.  Osteoporosis  Asian region is considered to be on the verge of an emerging osteoporosis epidemic  50% of the world’s osteoporotic.
Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.
Petranova T1, Boyanov M2, Shinkov A3, Petkova R4, Psachoulia E5
This patient has a total hip bone mineral density (BMD) of 0
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
THE EFFECTIVENESS OF ANNUAL ZOLEDRONIC ACID INFUSION VERSUS ORAL BISPHOSPHONATE: A MODELLING APPROACH Terence Ong1, 2, Matthey Jones3, Opinder Sahota1.
Mean scores for symptoms of mental illness between 1994/95 and 2004/05 in participants aged 10–11 years (A), between 1996/97 and 2007/08 in those aged.
Chapter 55: Cost-Effectiveness of Osteoporosis Treatment
Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX vs CAROC Reporting: Results From a Randomized Controlled Trial  Karen A. Beattie,
Osteoporosis Diagnosis 9/21/2018 OSTEOPOROSIS.
Prediabetes Screening and Monitoring
Bone Biology and Osteoporosis: Back to the Basics
Figure 3 Semantic model of the active surveillance (AS) timeline
2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada Papaioannou A, et al. CMAJ 2010 Oct 12. [Epub ahead of print].
Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.
Irish Hip Fracture Database
Evaluation of Different Screening Tools for Predicting Femoral Neck Osteoporosis in Rural South Indian Postmenopausal Women  Kripa Elizabeth Cherian,
Deciding on Pharmacological Treatment Post Fracture
Bone Biology and Osteoporosis: Back to the Basics
Figure 1 The trajectory of cognitive ageing
$13.8 Billion Hip Fractures $8.68 billion (63.1%)
Deciding on Pharmacological Treatment Post Fracture
Brian Lentle, MD, Angela M. Cheung, MD, PhD, David A
Bisphosphonate exposure and Atypical Femoral Fractures
Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.
Bone Biology and Osteoporosis: Back to the Basics
Combined Vertebral Fracture Assessment and Bone Mineral Density Measurement: A Patient-friendly New Tool with an Important Impact on the Canadian Risk.
Intensity of statin treatment and possible lipid lowering treatment intolerance and/or ineffectiveness issues among patients with type 2 diabetes (aged.
Kerry Siminoski, MD, FRCPC, Margaret O'Keeffe, MD, FRCPC, Jacques P
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Interpretation The World Health Organization (WHO) Osteoporosis Guidelines (T Score vs Z score) A Z-score less than –2 indicates the diagnosis is below.
Osteoporosis: Definition
Figure 2. Patient stratification by the reported duration of symptoms and disease severity at the time of assessment Patient stratification by the reported.
Cases of and deaths from cervical cancer, with associated incidence and mortality (rates per women), among Canadian women (2002–2006) by age group.
Hypothetical pathway for the association between exposure to household disinfectant and body mass index (BMI) z score at age 3 years. a, b1, ADE, ACME.
Figure 1. Relative risks of vertebral, hip, and nonvertebral fractures (and 95% CIs) in response to the treatments for ... Figure 1. Relative risks of.
Radiographic views of (A) an atypical femoral fracture that occurred spontaneously in a woman after six years of treatment with a bisphosphonate and (B)
Effect of methylprednisolone versus placebo on the risk of acute kidney injury in a subsample of patients with serial postoperative serum creatinine assessments.
Grace K. Mahoney, MS, Henry J. Henk, PhD, Rozalina G. McCoy, MD, MS 
Cases of and deaths from prostate cancer, with associated age-standardized incidence and mortality (per men), among Canadian men aged 45 years.
Fig. 1: Ampule of vitamin K
Spasticity as measured by mean combined scores on the modified Ashworth scale, before and after treatment, on each day of each phase of the trial. Spasticity.
Clinical pathway for organ donation in conscious, competent patients in Canada. Clinical pathway for organ donation in conscious, competent patients in.
Subjects Randomized to Denosumab or Bisphosphonate Therapy
Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.
Baseline characteristics of people who inject drugs enrolled in the Montreal Hepatitis C Cohort (2004–2017), by prescribed dosage of opioid agonist treatment,
Algorithm for the treatment of testosterone deficiency syndrome (TDS)
Hazard ratios for associations between incident hepatitis C virus infection and prescribed dosage of opioid agonist treatment, categorized according to.
Fig. 3: Theoretical relation between musculoskeletal fitness and independent living across a person's lifespan. Fig. 3: Theoretical relation between musculoskeletal.
Presentation transcript:

Figure 1: Assessment of basal 10-year risk of fracture with the 2010 tool of the Canadian Association of Radiologists and Osteoporosis Canada. Figure 1: Assessment of basal 10-year risk of fracture with the 2010 tool of the Canadian Association of Radiologists and Osteoporosis Canada. The T-score for the femoral neck should be derived from the National Health and Nutrition Education Survey III reference database for white women. Fragility fracture after age 40 or recent prolonged use of systemic glucocorticoids increases the basal risk by one category (i.e., from low to moderate or moderate to high). This model reflects the theoretical risk for a hypothetical patient who is treatment-naive; it cannot be used to determine risk reduction associated with therapy. Individuals with a fragility fracture of a vertebra or hip and those with more than one fragility fracture are at high risk of an additional fracture. Alexandra Papaioannou et al. CMAJ 2010;182:1864-1873 ©2010 by Canadian Medical Association